Nuo Therapeutics, Inc. (AURX) Net income 2017–2025
Nuo Therapeutics, Inc. (AURX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$2.5MFY2025 · since FY2017: -$15.0M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.5M | -8.1% |
| FY2024 | -$2.3M | +26.7% |
| FY2023 | -$3.2M | +0.0% |
| FY2022 | -$3.2M | -3398.1% |
| FY2021 | -$90,670 | +0.2% |
| FY2020 | -$90,870 | +92.4% |
| FY2019 | -$1.2M | +22.5% |
| FY2018 | -$1.5M | +89.7% |
| FY2017 | -$15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AURX financial trends
AURX RevenueAURX Net marginAURX Gross profitAURX Gross marginAURX Operating incomeAURX Operating marginAURX Operating cash flowAURX Free cash flowAURX Capital expendituresAURX Return on equityAURX Stock buybacksAURX Dividends paidAURX Total assetsAURX Total liabilitiesAURX Shareholders’ equityAURX overview →